Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

✍ Scribed by Lee, S; Park, Y H; Kim, K H; Cho, E Y; Ahn, Y C; Kim, K; Shim, Y-M; Ahn, J S; Park, K; Im, Y-H

• Book ID: 111717669
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 428 KB
• Volume: 103
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6605831